Ending the week with a step forward on PBM reform, and a look at how climate change is impacting our health in more ways than one. (508 words, 2 minutes, 32 seconds)
Two hearings yesterday highlighted incredible biopharmaceutical advances and how policy can help or hinder access to them. Plus, BIO Impact registration is now open—here’s what you need to know. (741 words, 3 minutes, 42 seconds)
We recap what happened at yesterday’s markup of PBM legislation, and look at how gene editing could eliminate allergens from eggs. (495 words, 2 minutes, 28 seconds)
A busy week in Washington wraps with a Senate hearing on PBMs, House hearings on agriculture, and the final day of the USITC’s hearing on the expansion of the COVID IP waiver. (748 words, 3 minutes, 44 seconds)
We recap what HHS Secretary Becerra said yesterday about everything from drug pricing to PBMs, and get ready for more hearings today, including the USITC’s hearing on the COVID IP waiver. (674 words, 3 minutes, 22 seconds)
Happy Friday. We recap yesterday’s hearing on the Pharmacy Benefit Manager Transparency Act and what BIO says about it—and look at why 2023 could be the year of RSV (in a good way). (610 words, 3 minutes, 3 seconds)Good Day BIO will take a break on Monday, February 20 for Presidents’ Day. We’ll return to our regular publishing schedule on Tuesday, February 21. In the meantime, keep an eye on Bio.News for breaking news.
New analysis tells the truth about drug prices, while new research highlights the need for biotech climate solutions. (708 words, 3 minutes, 32 seconds)
Happy Monday. We have more details on Biden’s EO on addressing prescription drug prices—and what BIO says about it—as well as the UN’s just-launched One Health action plan. (652 words, 3 minutes, 15 seconds)
A new analysis of Texas data shows—surprise, surprise—PBMs don’t pass on rebates and savings from drug makers to patients. Plus, we look at how biotech is resurrecting what’s considered Latin America’s oldest beer. Meanwhile, we’re keeping an eye on the House, which could vote on price controls as soon as tomorrow. (650 words, 3 minutes, 15 seconds)
Lots of news today from Capitol Hill on PBMs, ARPA-H, and a new insulin bill—plus, BIO’s comments to OSTP on sustainable chemistry. (725 words, 3 minutes, 37 seconds)